Generic Content – Paclitaxel(Protein-bound particles), Manufactured By: Biocon Ltd at Abraxis BioScience, USA

ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

Available As: 100 Mg Injection